Home › NCT07192887
Thebaine Urine Testing
RecruitingObservational studyHealthy volunteers welcome
Clinical Feasibility of Thebaine Urine Mass Spectrometry Drug Testing
Who can join
Ages 18 to 65 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Male or female * Ages 18-65 * Healthy Exclusion Criteria: * Allergy to poppy seeds, or any of the related food stuffs used in the study * Celiac disease or gluten sensitivity * Ongoing or opioid use in the past 6 months * History of renal or hepatic disease or dysfunction * Inability or unwillingness to give repeated urine specimens * Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study * Non-English speakers (due to study materials being in English) * BMI greater than 30 * Antibiotic use in the previous 2 months * Recent ingestion of poppy seeds from the previous 7 days
About the study
To develop and validate a urine drug screen to detect thebaine.
Sponsor: Children's Hospital Medical Center, Cincinnati · Participants: 20 · Started: May 7, 2025
Contact the study team
- Charlotte Walter, MD · Phone: 513-636-4408
Official record on ClinicalTrials.gov — NCT07192887
Locations in the U.S.
| Ohio | Cincinnati Children's Hospital Medical Center, Cincinnati |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.